WHITTIER TRUST CO - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 121 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2024$2,450
-5.5%
2890.0%0.00%
Q1 2024$2,592
-20.2%
2890.0%0.00%
Q4 2023$3,248
+30.2%
2890.0%0.00%
Q3 2023$2,494
-16.6%
2890.0%0.00%
Q2 2023$2,991
-4.6%
2890.0%0.00%
Q1 2023$3,135
-3.3%
2890.0%0.00%
Q4 2022$3,242
+8.1%
2890.0%0.00%
Q3 2022$3,0000.0%2890.0%0.00%
Q2 2022$3,0000.0%2890.0%0.00%
Q1 2022$3,0000.0%2890.0%0.00%
Q4 2021$3,000
+50.0%
2890.0%0.00%
Q3 2021$2,000
-50.0%
2890.0%0.00%
Q2 2021$4,000
-33.3%
2890.0%0.00%
Q1 2021$6,000
+20.0%
2890.0%0.00%
Q4 2020$5,000
+25.0%
2890.0%0.00%
Q3 2020$4,000
-33.3%
2890.0%0.00%
Q2 2020$6,000
-14.3%
2890.0%0.00%
Q1 2020$7,0000.0%2890.0%0.00%
Q4 2019$7,000
+16.7%
2890.0%0.00%
Q3 2019$6,000
+20.0%
2890.0%0.00%
Q2 2019$5,000
-54.5%
289
-40.3%
0.00%
Q1 2019$11,000
-8.3%
4840.0%0.00%
Q4 2018$12,000
-25.0%
4840.0%0.00%
Q3 2018$16,000
+45.5%
4840.0%0.00%
Q2 2018$11,000
-8.3%
4840.0%0.00%
Q1 2018$12,0004840.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Chescapmanager LLC 1,157,718$17,117,0002.77%
Baupost Group 8,735,168$129,149,0001.40%
Orbimed Advisors 6,219,110$91,950,0001.16%
Rubric Capital Management LP 550,747$8,143,0000.76%
Cormorant Asset Management, LP 650,072$9,611,0000.37%
Rock Springs Capital Management LP 824,018$12,183,0000.31%
Virtus ETF Advisers LLC 23,148$342,0000.18%
Tekla Capital Management LLC 298,470$4,413,0000.16%
PEREGRINE CAPITAL MANAGEMENT LLC 412,594$6,100,0000.16%
NJ State Employees Deferred Compensation Plan 38,142$564,0000.10%
View complete list of THERAVANCE BIOPHARMA INC shareholders